Blueberry Funded Review 2027Core Trading Conditions and Fees

Blueberry Funded review 2027: seven account types from a broker-linked firm

Blueberry Funded launched in 2024 and was started by Dean Hyde, the founder of the Australian broker Blueberry Markets. It is one of a growing group of prop firms attached to a brokerage, and it uses that broker's trading environment. The firm offers a wide set of evaluation and instant accounts and, since late 2025, a separate futures business. This review covers the CFD programme for 2027.

Account types

The range is broad. Prime is a two-step challenge aimed at swing traders and users of automated systems. There are also standard one-step and two-step challenges, a Rapid challenge with a short time frame, a Synthetic account and two instant funding accounts called Elite and Lite. Account sizes go up to $200,000, and the cheapest entries cost around $30.

Prime in detail

The Prime challenge publishes its terms plainly. The targets are 8% and 6%, the daily drawdown is 4% and the maximum overall drawdown is 10%, with leverage of 1:30. Once funded, the split is 80% and payouts can be requested every 14 days. Breaches of trading rules on Prime follow a stepped process that begins with a review and warning.

Standard challenges

The one-step challenge has a 10% target. The standard two-step challenge has a 5% daily loss limit, measured from the higher of the previous day's balance or equity, and a 10% static maximum drawdown.

Profit split and scaling

The split starts at 80% on all accounts. On most of them it can rise to 90% through the scaling plan or an add-on. Scaling requires 10% net profit over three consecutive months together with a number of payouts. Each step increases the balance by 25%, to a maximum allocation of $2 million.

Payouts

The standard payout cycle is 14 days, with shorter cycles available on some accounts. Payouts are subject to a review. The firm reports more than $7 million paid.

Rule update in March 2026

Accounts opened after 12 March 2026 fall under a revised framework for prohibited strategies. If you read the help centre, make sure the article matches your purchase date and programme.

Platforms

MetaTrader 4, MetaTrader 5, DXtrade and TradeLocker have been offered, with availability depending on programme and region. Instruments include forex, indices, commodities and crypto CFDs.

Legal structure

The prop firm is operated by offshore companies and is a separate business from the regulated brokerage. The link to Blueberry Markets supports its credibility. It does not extend the broker's regulatory protection to prop accounts, which are simulated.

Blueberry Futures

A sister futures firm launched in November 2025 with one-phase evaluations and a 90% split. It has its own rules and platform.

Reputation

Reviews are generally positive, with a smaller base than the largest firms. Independent trust scores are moderate. As a newer programme it is still building its record.

Choosing an account

Prime is the clearest product and the natural choice for swing traders and automated systems. The standard two-step suits intraday traders who want a static 10% limit. Instant accounts cost more for less drawdown and make sense only for a tested, low-variance approach.

Pros and cons

• Broker-linked: connected to Blueberry Markets.
• Variety: seven account types.
• Platforms: MT4 and MT5 among the options.
• Published scaling rules: clear criteria for growth.
• Base split: 80%, higher only with scaling or add-ons.
• Short history: launched in 2024.

Who is Blueberry Funded for?

Blueberry Funded suits MetaTrader users who want a broker-connected firm and a choice of evaluation styles. Traders who want the highest split from day one will need to pay for it.

Verdict

Blueberry Funded is a sensible mid-market firm with clear terms on its main product. For 2027 it is worth a look, particularly the Prime challenge.

Blueberry Funded review: compare the alternatives

This Blueberry Funded review is part of our Top 40 Prop Trading Firms in 2027 ranking. To compare, read the DNA Funded review and the ThinkCapital review.